MedTrace Logo

Analgesia for Total Hip Arthroplasty With PENG Block (ATHAPENG)

NCT06954207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-05-01

No results posted yet for this study

Summary

Analgesia for Total Hip Arthroplasty with PENG block (ATHAPENG)

Conditions

  • Total Hip Arthroplasty for Osteoarthritis

Interventions

DEVICE

Non interventional. Data collection concerns routine procedures and monitoring devices

Non interventional. Physiological parameters under general anesthesia are collected (arterial pressure, heart rhythm, bispectral index, NOL index, temperature, total dose of remifentanil infusion, analgesic drugs infusions). After surgery, pain scores (NRS), motor function and time to ambulation are also collected.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-25
Primary Completion
2024-06-25
Completion
2025-03-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06954207 on ClinicalTrials.gov